End-of-day quote
Shenzhen S.E.
23:00:00 27/06/2024 BST
|
5-day change
|
1st Jan Change
|
1.66
CNY
|
-1.19%
|
|
-5.68%
|
-45.21%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,089
|
3,000
|
3,434
|
3,947
|
3,464
|
2,990
|
Enterprise Value (EV)
1 |
3,469
|
3,344
|
3,601
|
4,019
|
3,611
|
3,010
|
P/E ratio
|
30.4
x
|
101
x
|
-13.7
x
|
36.8
x
|
-23.7
x
|
-18.6
x
|
Yield
|
-
|
0.66%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.67
x
|
1.59
x
|
1.87
x
|
1.51
x
|
1.38
x
|
1.32
x
|
EV / Revenue
|
1.87
x
|
1.77
x
|
1.96
x
|
1.53
x
|
1.44
x
|
1.33
x
|
EV / EBITDA
|
15.7
x
|
17.5
x
|
69.5
x
|
11.4
x
|
141
x
|
-153
x
|
EV / FCF
|
-9.55
x
|
52.6
x
|
12.3
x
|
44.6
x
|
-38.3
x
|
6.22
x
|
FCF Yield
|
-10.5%
|
1.9%
|
8.1%
|
2.24%
|
-2.61%
|
16.1%
|
Price to Book
|
1.5
x
|
1.44
x
|
1.9
x
|
2.06
x
|
1.95
x
|
2.18
x
|
Nbr of stocks (in thousands)
|
986,833
|
986,833
|
986,833
|
986,833
|
986,833
|
986,833
|
Reference price
2 |
3.130
|
3.040
|
3.480
|
4.000
|
3.510
|
3.030
|
Announcement Date
|
28/03/19
|
19/05/20
|
28/04/21
|
28/04/22
|
28/04/23
|
28/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,855
|
1,885
|
1,834
|
2,620
|
2,510
|
2,264
|
EBITDA
1 |
220.5
|
191.5
|
51.82
|
352.6
|
25.62
|
-19.64
|
EBIT
1 |
120.1
|
88.31
|
-57.6
|
246.1
|
-75.88
|
-105.4
|
Operating Margin
|
6.48%
|
4.69%
|
-3.14%
|
9.39%
|
-3.02%
|
-4.66%
|
Earnings before Tax (EBT)
1 |
112.1
|
42.63
|
-262.5
|
145.6
|
-170.1
|
-184.2
|
Net income
1 |
102
|
25.01
|
-250.2
|
107.3
|
-145.9
|
-160.7
|
Net margin
|
5.5%
|
1.33%
|
-13.64%
|
4.1%
|
-5.81%
|
-7.1%
|
EPS
2 |
0.1030
|
0.0300
|
-0.2536
|
0.1087
|
-0.1479
|
-0.1628
|
Free Cash Flow
1 |
-363.2
|
63.54
|
291.8
|
90.14
|
-94.4
|
483.7
|
FCF margin
|
-19.58%
|
3.37%
|
15.91%
|
3.44%
|
-3.76%
|
21.36%
|
FCF Conversion (EBITDA)
|
-
|
33.18%
|
562.99%
|
25.57%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
254.03%
|
-
|
84%
|
-
|
-
|
Dividend per Share
|
-
|
0.0200
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/03/19
|
19/05/20
|
28/04/21
|
28/04/22
|
28/04/23
|
28/04/24
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
34.38
|
Net margin
|
-
|
EPS
2 |
0.0348
|
Dividend per Share
|
-
|
Announcement Date
|
28/04/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
380
|
344
|
166
|
72.1
|
147
|
19.8
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.725
x
|
1.797
x
|
3.211
x
|
0.2044
x
|
5.751
x
|
-1.009
x
|
Free Cash Flow
1 |
-363
|
63.5
|
292
|
90.1
|
-94.4
|
484
|
ROE (net income / shareholders' equity)
|
5.03%
|
1.21%
|
-12.9%
|
5.76%
|
-7.7%
|
-8.8%
|
ROA (Net income/ Total Assets)
|
2.55%
|
1.78%
|
-1.2%
|
5.16%
|
-1.54%
|
-2.14%
|
Assets
1 |
3,996
|
1,409
|
20,777
|
2,081
|
9,479
|
7,520
|
Book Value Per Share
2 |
2.080
|
2.100
|
1.830
|
1.940
|
1.800
|
1.390
|
Cash Flow per Share
2 |
0.3000
|
0.2300
|
0.3600
|
0.4600
|
0.4000
|
0.4000
|
Capex
1 |
9.16
|
18.6
|
23.5
|
28.8
|
157
|
322
|
Capex / Sales
|
0.49%
|
0.99%
|
1.28%
|
1.1%
|
6.27%
|
14.23%
|
Announcement Date
|
28/03/19
|
19/05/20
|
28/04/21
|
28/04/22
|
28/04/23
|
28/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -45.21% | 225M | | +0.73% | 99.64B | | -11.98% | 58.77B | | +75.71% | 48.81B | | +5.26% | 34.94B | | +0.61% | 31.15B | | +3.47% | 18.62B | | +17.33% | 17.44B | | +5.92% | 13.51B | | -6.67% | 12.73B |
Other Commodity Chemicals
|